Enliven Therapeutics, Inc. (ELVN) stock
ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$44.89−1.96 (-4.18%)
Close on Nov 18, 2026Market cap $3.29BP/E –Yield –
Enliven Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Enliven Therapeutics's market cap was $3.75B on Nov 11, 2026, against $1.28B a year earlier. Over the last 5 years it ranged from $14.76M to $4.24B, with a median of $912.62M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.75B | +310.9% |
| 2025 | Dec 31, 2025 | $912.62M | -14.2% |
| 2024 | Dec 31, 2024 | $1.06B | +86.4% |
| 2023 | Dec 29, 2023 | $570.28M | +1005.0% |
| 2022 | Dec 30, 2022 | $51.61M | +81.9% |
| 2021 | Dec 31, 2021 | $28.38M | -84.6% |
| 2020 | Dec 31, 2020 | $183.92M | – |
See a number that looks wrong?